ESTRELLA IMMUNOPHARMA, INC. Shares Outstanding (Cover Page)
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Shares Outstanding (Cover Page) of 43.50 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 43.50M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 43.03M shares.
- 2026-03-12: Entity Common Stock, Shares Outstanding 42.67M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 37.77M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 43.50M shares 10-Q · filed 2026-08-13 |
| 2026-05-11 | 43.03M shares 10-Q · filed 2026-05-18 |
| 2026-03-12 | 42.67M shares 10-K/A · filed 2026-04-30 |
| 2025-11-10 | 37.77M shares 10-Q · filed 2025-11-12 |
| 2025-08-06 | 37.07M shares 10-Q · filed 2025-08-12 |
| 2025-05-13 | 36.17M shares 10-Q · filed 2025-05-14 |
| 2025-03-20 | 36.17M shares 10-KT · filed 2025-03-25 |
| 2024-11-11 | 36.18M shares 10-Q · filed 2024-11-14 |
| 2024-09-20 | 36.19M shares 10-K/A · filed 2024-10-28 |
| 2024-05-13 | 36.38M shares 10-Q · filed 2024-05-15 |
| 2024-02-12 | 36.61M shares 10-Q · filed 2024-02-14 |
| 2023-11-16 | 35.20M shares 10-Q · filed 2023-11-20 |
| 2023-07-31 | 2.17M shares 10-Q · filed 2023-08-01 |
| 2023-05-15 | 5.85M shares 10-Q · filed 2023-05-18 |
| 2023-03-14 | 2.33M shares 10-K · filed 2023-03-14 |
| 2022-11-14 | 5.85M shares 10-Q · filed 2022-11-14 |
| 2022-08-08 | 5.85M shares 10-Q · filed 2022-08-08 |
| 2022-05-13 | 5.85M shares 10-Q · filed 2022-05-16 |
| 2022-03-29 | 5.85M shares 10-K · filed 2022-03-29 |
| 2021-11-10 | 5.85M shares 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |